Imerslund-Gräsbeck syndrome
Imerslund-Gräsbeck syndrome (IGS), also known as selective vitamin B12 malabsorption with proteinuria, is a rare autosomal recessive disorder characterized by megaloblastic anemia and proteinuria. The syndrome was first described by Olga Imerslund in Norway and Ralph Gräsbeck in Finland, hence the name Imerslund-Gräsbeck syndrome.
Etiology[edit | edit source]
IGS is caused by mutations in either the AMN or CUBN genes. These genes are responsible for the production of proteins that work together to absorb vitamin B12 in the small intestine. Mutations in these genes disrupt the absorption process, leading to vitamin B12 deficiency.
Clinical Features[edit | edit source]
The main clinical features of IGS include megaloblastic anemia and proteinuria. Megaloblastic anemia is a condition characterized by larger than normal red blood cells and a decreased number of red blood cells. Proteinuria is a condition where an excess amount of protein is present in the urine. Other symptoms may include fatigue, weakness, pallor, and failure to thrive in children.
Diagnosis[edit | edit source]
Diagnosis of IGS is based on clinical features, laboratory tests, and genetic testing. Laboratory tests may show low levels of vitamin B12 in the blood, megaloblastic anemia, and proteinuria. Genetic testing can confirm the diagnosis by identifying mutations in the AMN or CUBN genes.
Treatment[edit | edit source]
Treatment for IGS involves lifelong vitamin B12 injections to correct the deficiency. With regular treatment, individuals with IGS can lead normal, healthy lives.
Epidemiology[edit | edit source]
IGS is a rare disorder, with an estimated prevalence of 1 in 200,000 to 1 in 1,000,000. It is more common in certain populations, such as the Finnish and Norwegian populations, due to a higher frequency of the disease-causing mutations in these populations.
See Also[edit | edit source]
NIH genetic and rare disease info[edit source]
Imerslund-Gräsbeck syndrome is a rare disease.
| Imerslund-Gräsbeck syndrome Resources | |
|---|---|
|
 |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
